Platform for testing, development and approval of cardiovascular implants planned

Twelve partners from eight countries want to establish a simulation environment “SIMCor” for the testing, development and approval of cardiovascular implants over the next three years. The European Union (EU) is funding the project over three years with a total of 7.2 million euros. The Charité in Berlin is coordinating the project.
The SIMCor project now being funded is intended to establish an open computer platform for device manufacturers, medical institutes and regulatory authorities. It will enable device testing along the entire development process, i.e. from pure computer modeling to virtual animal and clinical studies.

As an example, the researchers plan to apply these processes to two representative cardiovascular implants: Transcatheter Aortic Valve Implants (TAVI) and pulmonary artery pressure sensors.

Author(s) Source
© hil/aerzteblatt.de aerzteblatt.de, 01.02.2021
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. The content usually is shortened to make it understandable for many. Read the linked original text if you are interested. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know